Study guide

2.2 Physical Examination & Anatomical Wound Classification

ABWM Certified Wound Specialist CWS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the ABWM CWS Exam 1.2 How to Use This Study Guide & Blueprint Strategy

2 Chapter 2: Comprehensive Patient & Wound Assessment

2.1 Patient History & Systemic Risk Factors 2.2 Physical Examination & Anatomical Wound Classification 2.3 Quantitative Wound Measurement & Documentation 2.4 Bioburden & Infection Assessment

3 Chapter 3: Vascular Assessment & Diagnostic Testing

Section 3.1: Ankle-Brachial Index (ABI) & Toe-Brachial Index (TBI) Interpretation Section 3.2: Advanced Vascular Diagnostics Section 3.3: Neuropathic & Sensory Assessment

4 Chapter 4: Laboratory, Imaging & Diagnostic Approaches

Section 4.1: Laboratory Evaluation in Wound Care Section 4.2: Imaging Modalities for Wounds & Bone Section 4.3: Differential Diagnosis of Recalcitrant & Atypical Wounds

5 Chapter 5: Physiology of Wound Healing & Tissue Repair

5.1 Hemostasis & Inflammatory Phase Dynamics 5.2 Proliferative & Remodeling Phases 5.3 Growth Factors & Extracellular Matrix (ECM)

6 Chapter 6: Biofilm Biology & Wound Bed Preparation

6.1 Biofilm Pathophysiology & Management Strategies 6.2 TIME Framework & Wound Bed Preparation 6.3 Moisture Balance & Exudate Management

7 Chapter 7: Pressure Injuries & Moisture-Associated Skin Damage

7.1 Pressure Injury Pathophysiology & NPIAP Staging 7.2 Risk Assessment Tools & Support Surface Selection 7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis

8 Chapter 8: Lower Extremity Ulcers (Venous, Arterial & Mixed)

Section 8.1: Venous Leg Ulcers & CEAP Classification Section 8.2: Arterial Ulcers & Peripheral Artery Disease Section 8.3: Mixed Venous-Arterial Ulcers & Lymphedema

9 Chapter 9: Diabetic Foot Ulcers & Neuropathic Wounds

Section 9.1: Diabetic Foot Ulcer Pathophysiology & Classification Section 9.2: Diabetic Foot Infection & Osteomyelitis Management

10 Chapter 10: Thermal Injuries, Surgical Wounds & Special Etiologies

Section 10.1: Burn Injuries & Thermal Damage Section 10.2: Surgical Wounds, Dehisced Incisions & Fistulas Section 10.3: Dermatological, Pediatric & Miscellaneous Wound Types

11 Chapter 11: Debridement & Topically Applied Therapies

Section 11.1: Debridement Modalities & Selection Section 11.2: Wound Dressing Selection & Categories Section 11.3: Topical Antimicrobial Agents & Antiseptics

12 Chapter 12: Compression Therapy & Advanced Off-Loading

Section 12.1: Compression Therapy Modalities & Science Section 12.2: Off-Loading Devices & Biomechanical Protection

13 Chapter 13: Advanced & Adjunctive Wound Therapies

Section 13.1: Negative Pressure Wound Therapy (NPWT) Section 13.2: HBOT, Biophysical Agents & Advanced Biologics Section 13.3: Systemic Nutrition, Hydration & Pain Management

14 Chapter 14: Professional Practice, Reimbursement & Interprofessional Care

14.1 Professional Ethics, Scope of Practice & ABWM Guidelines 14.2 Documentation, Coding & Reimbursement Standards 14.3 Interprofessional Team Roles & Quality Improvement

2.2 Physical Examination & Anatomical Wound Classification

Key Takeaways Explain This Topic AI

Systematic periwound evaluation must differentiate blanchable reactive hyperemia from non-blanchable erythema (Stage 1 pressure injury), maceration, induration, and venous stasis dermatitis.

Plantar calluses represent hyperkeratotic responses to repetitive mechanical stress; in neuropathic patients, they act as internal pressure points and pre-ulcerative lesions requiring prompt sharp debridement.

Accurate characterization of wound bed tissue types—distinguishing viable beefy red granulation tissue from stringy yellow slough, black leathery eschar, and pale pink migrating epithelium—is critical for baseline documentation and debridement selection.

Lipodermatosclerosis, characterized by fibrotic induration of the lower leg ('inverted champagne bottle' appearance) and hemosiderin hyperpigmentation, is a hallmark of chronic venous hypertension.

Stable, dry, adherent, non-erythematous eschar on an ischemic heel or arterial limb should NOT be debrided until arterial perfusion is restored or clinical signs of infection emerge.

Last updated: July 2026

Physical Examination & Anatomical Wound Classification

Physical examination of the patient with a chronic wound requires a structured, objective, and reproducible approach. The clinician must look beyond the immediate defect to evaluate the surrounding periwound skin, regional anatomical structures, peripheral vascular status, and overall tissue viability. Accurate identification of periwound pathological features and precise classification of wound bed tissue composition provide the essential baseline data required to establish etiology, monitor healing trajectory, and select appropriate local therapies.

1. Systematic Physical Examination Protocol

Examination of the wound and extremity should be conducted in a well-lit environment with the patient properly positioned and exposed. Assessment follows a logical hierarchy:

Visual & Palpatory Inspection: Assess overall limb symmetry, skin color, hair growth distribution, skin temperature (using dorsal hand surface or infrared thermometry), and edema (pitting vs. non-pitting).

Vascular & Neurological Screening: Palpate peripheral pulses (dorsalis pedis, posterior tibial, popliteal, femoral) and perform 10-gram Semmes-Weinstein monofilament testing.

Periwound Assessment: Inspect skin integrity within a 10 cm radius of the wound margin.

Wound Bed Examination: Evaluate tissue types, exudate character, and anatomical depth.

2. Periwound Skin Evaluation & Clinical Signatures

The periwound tissue reflects the chronic forces, moisture levels, and vascular dynamics acting upon the wound. Recognizing specific periwound dermatological conditions is key to preventing wound enlargement.

Maceration

Maceration appears as softened, soggy, waterlogged, and pale white tissue surrounding the wound margin. It occurs when excessive wound exudate or trapped moisture saturates the epidermal stratum corneum, breaking down intracellular desmosomes:

Clinical Significance: Macerated tissue lacks mechanical strength, making the wound margin susceptible to enlargement, erosion, and secondary fungal (e.g., Candida ) or bacterial superinfection.

Management: Implement absorbent primary dressings (alginates, gelling fibers, foams), apply barrier films (cyanoacrylate or polymer barriers), and address underlying exudate etiologies.

Erythema: Blanchable vs. Non-Blanchable vs. Cellulitis

Erythema indicates cutaneous capillary congestion and inflammation. Distinguishing the etiology of redness is critical:

Blanchable Erythema (Reactive Hyperemia): Redness that temporarily turns white upon finger pressure, indicating intact microvascular capillary beds responding to transient pressure or friction.

Non-Blanchable Erythema: Redness that persists under direct pressure. Indicates microvascular thrombosis, capillary hemorrhage, and structural tissue damage—the hallmark of Stage 1 pressure injuries.

Cellulitis: Spreading periwound erythema accompanied by localized warmth, induration, edema, and tenderness extending > 2 cm >2\text{ cm} > 2 cm beyond the wound margin, indicating invasive soft tissue infection.

Induration

Induration is an abnormal firmness, hardening, or loss of elasticity in the periwound soft tissue detected by palpation. It reflects subcutaneous edema, cellular infiltration, deep tissue infection, or chronic dermal fibrosis.

Calluses (Hyperkeratosis)

Hyperkeratosis is the thickening of the stratum corneum in response to repetitive mechanical friction, pressure, or shear stress:

Neuropathic Significations: In patients with diabetic peripheral neuropathy and loss of protective sensation, plantar calluses act as rigid internal pressure points. Mechanical forces concentrate beneath the callus, causing subcutaneous tissue hemorrhage, fat pad necrosis, and subkeratotic ulceration.

Management: Plantar calluses must undergo complete sharp debridement to level the skin surface and relieve sub-lesional mechanical shear.

Stasis Dermatitis & Lipodermatosclerosis

Associated with chronic venous insufficiency and lower extremity venous hypertension:

Hemosiderin Staining: High venous pressures cause red blood cell extravasation into the dermis. Hemoglobin breaks down into hemosiderin, depositing insoluble iron complexes that stain the skin a permanent reddish-brown or bronze color.

Lipodermatosclerosis: Chronic subcutaneous inflammation leads to severe pericapillary fibrin deposition, dermal fibrosis, and subcutaneous fat necrosis. Over time, the lower leg becomes severely indurated, bound down, and narrowed, contrasting with proximal calf edema to form the classic "inverted champagne bottle" leg contour.

Periwound Eczema & Contact Dermatitis

Periwound scaling, vesicles, weeping, and severe pruritus may indicate irritant contact dermatitis (from wound exudate) or allergic contact dermatitis (triggered by topical antibiotics like neomycin/bacitracin, adhesive tapes, or rubber components in dressings).

3. Periwound Pathology Summary Table

Condition Visual Presentation Primary Pathophysiology Clinical Action

Maceration White, soggy, softened periwound skin edges. Prolonged exposure to excess exudate/moisture. Apply barrier film; select absorbent gelling/foam dressing.

Non-Blanchable Erythema Persistent redness under pressure; intact skin. Microvascular thrombosis/damage (Stage 1 pressure injury). Remove pressure/shear; implement structural offloading.

Callus (Hyperkeratosis) Thickened, yellow-brown hyperkeratotic plaque. Repetitive mechanical pressure and shear. Perform sharp debridement; prescribe custom offloading orthotics.

Lipodermatosclerosis Wood-like induration; "inverted champagne bottle" leg. Chronic venous hypertension, dermal fibrosis, fat necrosis. Initiate progressive compression therapy (if ABI ≥ 0.8 \ge 0.8 ≥ 0.8 ).

Contact Dermatitis Erythematous, scaling, weeping, pruritic skin. Allergic or irritant response to topicals/adhesives. Eliminate offending agent; apply topical low-potency steroid.